Searchable abstracts of presentations at key conferences in endocrinology

ea0032p369 | Diabetes | ECE2013

Relation of serum chemerin level with markers of atherosclerosis in diabetes and prediabetes

Aydin Kadriye , Canpolat Ugur , Dural Muhammet , Akin Safak , Karakaya Jale , Aytemir Kudret , Gurlek Alper

Introduction: Chemerin is a novel adipokine that is correlated with adipocyte differentiation, glucose metabolism and inflammation, but its role remains to be elucidated in atherosclerosis particularly in diabetes and prediabetes. We aimed to investigate the relation of serum chemerin levels with markers of atherosclerosis as exemplified by pulse wave velocity (PWV), carotid intima media thickness (CIMT), and carotid plaque presence in these groups.Metho...

ea0022p351 | Diabetes | ECE2010

Increased serum nesfatin-1 levels in patients with impaired glucose tolerance

Gulcelik Nese Ersoz , Akin Safak Cavus , Aksoy Duygu Yazgan , Karakaya Jale , Usman Aydan

Objective: Nesfatin was found to be co-localized with insulin in pancreatic β cells and its levels were decreased in type 2 diabetic patients. In order to investigate the role of nesfatin in carbohydrate metabolism, we measured baseline nesfatin-1 levels and its response to glucose load in patients with impaired glucose tolerance (IGT) and in healthy subjects.Subjects and methods: Fourteen patients with IGT and, 13 age and body mass index matched co...